What is the recommended treatment for intertrigo?

Intertrigo Treatment

For uncomplicated intertrigo, keep the affected skin folds dry and apply a topical barrier product containing zinc oxide or similar moisture-wicking agents; if secondary candidal infection is present or suspected, add topical nystatin or an azole antifungal cream twice daily.

Initial Assessment and Risk Factor Management

The foundation of intertrigo treatment requires identifying and addressing predisposing factors 1, 2. Key contributors include:

• Moisture and friction: Primary mechanical cause in skin folds
• Obesity and diabetes: Major risk factors requiring optimization
• Immunosuppression: HIV, corticosteroid use, chemotherapy
• Local factors: Poor hygiene, occlusive clothing, fungal colonization

Patients must be educated on weight reduction and glycemic control, as these directly impact recurrence rates 2.

Treatment Algorithm by Severity

Mild to Moderate Uncomplicated Intertrigo

First-line approach:

• Moisture control: Apply barrier sprays or lotions containing zinc oxide, zinc gluconate-taurine complex, panthenol, and glycerin twice daily 3
• Moisture-wicking textiles: Place within skin folds to reduce skin-on-skin friction 1
• Structured skin care routine: Gentle cleansing, thorough drying (including with hair dryer on cool setting), and immediate barrier application

Recent evidence shows barrier products containing tapioca starch, spent grain wax, and Butyrospermum parkii extract achieve equivalent anti-inflammatory efficacy to 1% hydrocortisone cream with superior pruritus reduction 4. The advantage is avoiding corticosteroid-related complications, particularly candidal superinfection.

Candidal Intertrigo (Secondary Infection)

When satellite pustules, white exudate, or characteristic erythematous patches with scaling borders are present, add antifungal therapy 2:

Topical treatment (preferred for localized disease):

• Nystatin cream/ointment: Apply 2-4 times daily for 7-14 days
• Azole antifungals: Clotrimazole, miconazole, or ketoconazole cream twice daily for 7-14 days
• These can be combined with low-potency topical corticosteroids (hydrocortisone 1%) for severe inflammation, but limit corticosteroid use to 7-14 days maximum to prevent fungal proliferation

Systemic treatment (for extensive or refractory disease):

• Oral fluconazole 100-200 mg daily for 7-14 days 5
• Reserve for patients with widespread involvement, immunosuppression, or failed topical therapy

Bacterial Intertrigo (Gram-Negative)

Gram-negative bacterial intertrigo presents with weeping, erosive, painful lesions, often with fissures and exudate 6. Pseudomonas aeruginosa is the predominant pathogen (48% of cases).

Treatment approach:

• Culture the exudate to guide antibiotic selection
• Topical corticosteroids (moderate potency) can be used and are well-tolerated, though they don't reduce disease duration 6
• Systemic antibiotics targeting gram-negative organisms if severe or extensive
• Address associated eczema (present in >50% of cases) with appropriate anti-inflammatory therapy

Common pitfall: This condition has a median duration of 56-61 days and high recurrence rates (7-21%), so set realistic expectations 6.

Refractory or Recurrent Cases

For patients with treatment-resistant or recurrent intertrigo 2:

1. Confirm diagnosis: Consider skin biopsy or advanced fungal cultures to exclude resistant organisms or alternative diagnoses
2. Evaluate for intestinal candidal colonization: May require systemic antifungal therapy
3. Check for periorificial infections: Treat concurrently
4. Chronic suppressive therapy: For recurrent candidal intertrigo, consider fluconazole 100 mg three times weekly 5
5. Optimize immunosuppression: In HIV patients, ensure adequate antiretroviral therapy 5

Critical Management Principles

What NOT to do:

• Avoid high-potency topical corticosteroids in candidal intertrigo—they exacerbate fungal infections 4
• Don't use corticosteroids alone without addressing moisture and friction
• Avoid prolonged corticosteroid use (>2 weeks) without antifungal coverage

Essential patient education:

• Daily gentle cleansing and thorough drying of skin folds
• Immediate application of barrier products after bathing
• Use of absorbent powders (cornstarch, zinc oxide-based) to maintain dryness
• Wear loose-fitting, breathable clothing
• Consider moisture-wicking textile inserts for high-risk areas

The quality of evidence for intertrigo management remains low overall 1, but the consensus approach combining moisture control, barrier protection, and targeted antimicrobial therapy when indicated represents the current standard of care. The key to success is addressing underlying predisposing factors while maintaining meticulous skin fold hygiene.